Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVR
Hideyuki Kawashima, Yusuke Watanabe, Hirofumi Hioki, Ken Kozuma, Akihisa Kataoka, Makoto Nakashima, Fukuko Nagura, Yugo Nara, Fumiaki Yashima, Norio Tada, Toru Naganuma, Masahiro Yamawaki, Futoshi Yamanaka, Shinichi Shirai, Kazuki Mizutani, Minoru Tabata, Hiroshi Ueno, Kensuke Takagi, Masanori Yamamoto, Kentaro Hayashida
Topics & Concepts
MedicineHazard ratioAtrial fibrillationInternal medicineVitamin K antagonistConfidence intervalProportional hazards modelCardiologyPropensity score matchingValve replacementAnticoagulantWarfarinSurgeryStenosisAtrial Fibrillation Management and OutcomesCardiac Valve Diseases and TreatmentsVitamin K Research Studies